ALA 3.33% 14.5¢ arovella therapeutics limited

Mid-May Artimist marketing approval

  1. 2,314 Posts.
    lightbulb Created with Sketch. 332
    Thanks big dog for clarifying the oppies acquisition definition. It all seems reasonable now.

    Good news on the acquisition of our new non-exec Chairman. Here's an interesting post from megmutts.
    Post #: 33852393

    The big question now has to be what will the TGA do regarding the marketing approval of Arti. Will they ignore the ACM's rejection on the grounds of flawed experimental design and approve the product anyway. Or will reject it outright and the company will be required to appeal the decision.

    Prefer the formal but am expecting the latter.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
-0.005(3.33%)
Mkt cap ! $152.5M
Open High Low Value Volume
15.0¢ 15.0¢ 14.5¢ $38.90K 263.2K

Buyers (Bids)

No. Vol. Price($)
5 624656 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 628807 7
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.